Thai Journal of Pharmacology (Thai J Pharmacol) is a peer-reviewed journal publishing original research and review articles on pharmacology and related fields, i.e. pharmacodynamics, pharmacokinetics, pharmacotherapeutics, toxicology, clinical pharmacology, molecular pharmacology, pharmacogenetics/pharmacogenomics, comparative pharmacology, safety pharmacology, systems pharmacology, and pharmacoepidemiology.  Currently being abstracted and indexed by Thai Journal Citation Index (TCI - Tier 1) and ASEAN Citation Index (ACI).  

ISSN (Print):
0125-3832 (Printed since 1979 till 2018)
ISSN (Online):
2697-3928 (Starting from 2019)

Change of Editor-in-Chief


On 10 June 2021, Assoc. Prof. Dr. Rattima Jeenapongsa stepped down and from June 11, 2021, Professor Dr. Kesara Na-Bangchang will be our new Editor-in-Chief.  The Associate Editors and Editorial Team will be also changed.  The submission and review process will remain the same, and the contact e-mail address of the journal will be the same address:  

Call for Papers


Call for papers to publish in Thai Journal of Pharmacology, Volume 43 Number 2 (Jul-Dec 2021);  
Deadline: 15 October 2021.  See the detail at Online submission

Change in publication policy


Thai Journal of Pharmacology would like to inform the authors that there will be a change in journal  policy regarding publication language from January 2021.

All manuscripts submitted from January 1, 2021 must be written in English language only and Thai abstract is no longer required.  

Vol. 43 No. 1 (2021)

Published: 2021-06-09

Assessment of Cytotoxic Activities of 5 Cyclooxygenase Inhibitors Against Liver and Breast Cancers Cell Lines

Jiraporn Kuesap, Thitiya Traichokgul, Atitaya Chomphuchan, Wanna Chaijaroenkul


Investigating the Possible Interfering Effect of COX-2 Inhibitors on Antimalarial Activity of Mefloquine and Artesunate

Wanna Chaijaroenkul, Jirawadee Tippayapornswan, Maethee Vichitnontakarn, Kesara Na-Bangchang


Cancer Stem Cells, the Cellular Signaling, and Potential Therapeutic Targets in Lung Cancer

Nattamon Hongwiangchan, Pithi Chanvorachote, Sucharat Tungsukruthai


View All Issues